Get started
Work

Abstract PS12-02: Exploration of ctDNA Dynamics in the PACE Trial: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for HR+/HER2- Metastatic Breast Cancer

Year: 2024
Type: conference-abstract
DOI: 10.1158/1538-7445.sabcs23-ps12-02
Authors: Rinath Jeselsohn, Jingxin Fu, Yue Ren, Reshma Mahtani, Cynthia Ma, Angela DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy Miller, Yara Abdou, Elizabeth Riley, Rubina Qamar, Priyanka Sharma, Sonya Reid, Naomi Ko, Yuan Liu, Harold Burstein, Michelle DeMeo, Sara Tolaney, Erica Mayer
Institutions: Dana-Farber Cancer Institute, Washington University in St. Louis, University of Pennsylvania, Weill Cornell Medicine, Winship Cancer Institute, Indiana University, University of North Carolina at Chapel Hill, University of Kansas Medical Center, Vanderbilt-Ingram Cancer Center, Pfizer (United States)
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4396597233
Cites:
Cited by: 3
Related to: 10